Tuesday February 9 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

TASIGNA Pages on BioPortfolio:

Biotechnology News TASIGNA Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/TASIGNA-news.htm...

BioPortfolio News: Novartis - Video: Tasigna(R) Demonstrates Rapid...
Novartis - Video: Tasigna(R) Demonstrates Rapid... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/Video:_Tasigna(R)_Demonstra...

Biotechnology News Epstein-Barr Search
The just-released results of a large Phase III clinical trial, presented at a major medical meeting, show that Tasigna (nilotinib) 200 mg capsules ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Tasigna
TASIGNA prolongs the QT interval. Sudden deaths have been reported in patients receiving nilotinib. TASIGNA should not be used in patients with hypokalemia,
...
http://www.bioportfolio.com/indepth/Tasigna.html...

Biotechnology News EXJADE Search
2 Dec 2009 ... Late-breaking abstract to report data from pivotal trial of Tasigna versus Glivec in newly diagnosed patients with a form of chronic myeloid ...
http://www.bioportfolio.co.uk/EXJADE-news.htm...

BioPortfolio News: - Novartis Tasigna(R) (nilotinib) Trial...
Novartis Tasigna(R) (nilotinib) Trial... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/Novartis-Tasigna(R)-(niloti...

Biotechnology News SPRYCEL Search
ASH 2009: Novartis looks to position Tasigna as an alternative to Gleevec in ... While Tasigna's efficacy is impressive, it is unlikely that the drug will. ...
http://www.bioportfolio.co.uk/SPRYCEL-news.htm...

BioPortfolio News: Novartis - Novartis Tasigna(R) Trial Shows...
Novartis - Novartis Tasigna(R) Trial Shows... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/Novartis-Tasigna(R)-Trial-S...

Biotechnology News JANU_MET Search
2 /PRNewswire/ -- Novartis announced today that new data, including a late- breaking presentation on Tasigna, (nilotinib) 200 mg capsules in a form of ...
http://www.bioportfolio.co.uk/JANU_MET-news.htm...

BioPortfolio - Sermo - Tasigna Front Line Data Convincing But Not ...
According to the report, Oncologists find Tasigna front line data ... Interestingly, there is not much familiarity of Tasigna front line data in the
...
http://www.bioportfolio.com/news/Tasigna-Front-Line-Data-Con...

Results from other life science and pharmaceutical sites:

2 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...
Tasigna prolongs the QT interval (5.2). Sudden deaths have been reported in patients receiving nilotinib (5.3). Tasigna should ...
http://www.pharma.us.novartis.com/product/pi/pdf/tasigna.pdf...

Nilotinib - Wikipedia, the free encyclopedia
It was approved as Tasigna in the USA and the EU for drug-resistant chronic ... "FDA Approves Tasigna for Treatment of Philadelphia Chromosome Positive ...
http://en.wikipedia.org/wiki/Nilotinib...

Tasigna Label
A Medication Guide is required for distribution with Tasigna. ... Tasigna doses should be taken twice daily approximately 12 hours apart and should not be ...
http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089159.pdf...

Novartis Tasigna® trial shows superior results to Glivec® in ...
8 Dec 2009 ... Basel, December 8, 2009 - In a large Phase III clinical trial, Tasigna® ( nilotinib) demonstrated greater efficacy over Glivec® (imatinib)* ...
http://www.novartis.com/newsroom/media-releases/en/2009/1359...

FDA Approves Tasigna for Treatment of Philadelphia Chromosome ...
30 Oct 2007 ... The US Food and Drug Administration (FDA) has approved Tasigna (nilotinib) capsules for treatment of Philadelphia chromosome positive ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...

Novartis drug Tasigna® meets primary endpoint in pivotal trial ...
20 Oct 2009 ... Tasigna produced faster and deeper responses compared to Glivec as first-line treatment in Philadelphia chromosome-positive chronic myeloid ...
http://www.novartis.com/newsroom/media-releases/en/2009/1348...

Tasigna (nilotinib) capsules
15 Sep 2009 ... Tasigna (nilotinib) capsules Drug Safety Labeling Changes August 2009 MedWatch.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm1822...

Tasigna® shows rapid and deep responses in newly diagnosed ...
5 Jun 2009 ... Basel, June 5, 2009 - New data show that at 12 months newly diagnosed patients taking Tasigna® (nilotinib) to treat a life-threatening form ...
http://www.novartis.com/newsroom/media-releases/en/2009/1320...

TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication ...
Read this Medication Guide before you start taking Tasigna ... Swallow Tasigna capsules whole with water. Do not open Tasigna capsules. ...
http://www.pharma.us.novartis.com/product/pi/pdf/tasigna_pmg...

FDA Safety Changes: Metronidazole Injection, DexFerrum, INFeD, Tasigna
23 Sep 2009 ... The FDA has approved safety labeling revisions for metronidazole injection, iron dextran injection (DexFerrum and INFeD), and nilotinib HCl ...
http://www.medscape.com/viewarticle/709381...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.